|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by Oppenheimer on October 20, 2021. The analyst firm set a price target for 84.00 expecting SAGE to rise to within 12 months (a possible 102.80% upside). 28 analyst firms have reported ratings in the last year.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $41.42 last updated Fri Oct 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Sage Therapeutics.
Sage Therapeutics’s $Q3 earnings are confirmed for after-market on $November 2, 2021.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.